Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04392284
What this trial is testing

Developing an Adaptive Lifestyle Intervention Program in Family Medicine Clinics

Who this might be right for
Insulin ResistanceObesityDiabetes+3 more
University of Alabama at Birmingham 40
Testing effectiveness (Phase 2)Study completedNCT00001493
What this trial is testing

Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT01894347
What this trial is testing

Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)

Who this might be right for
Infection Resistant to Multiple Drugs
Charite University, Berlin, Germany 9
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Not applicableStudy completedNCT02063867
What this trial is testing

Active Bathing to Eliminate Infection (ABATE Infection) Trial

Who this might be right for
Healthcare Associated InfectionsMethicillin Resistant Staphylococcus AureusMulti Drug Resistant Organisms
University of California, Irvine 53
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Post-approval studies (Phase 4)Study completedNCT00187551
What this trial is testing

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Who this might be right for
HIV Infections
University of California, San Francisco 25
Not applicableStudy completedNCT04833231
What this trial is testing

The Relationship Between Renal Functions and Multi Drug Resistant Organisms

Who this might be right for
Chronic Kidney DiseaseGlomerular Filtration RateDrug Resistance
Konya Numune Hospital 133
Not applicableLooking for participantsNCT06353620
What this trial is testing

Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy

Who this might be right for
EpilepsyAngelman SyndromeDup15q Syndrome
IRCCS Eugenio Medea 120
Testing effectiveness (Phase 2)Study completedNCT01859923
What this trial is testing

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Multidrug Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableStudy completedNCT02175849
What this trial is testing

Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis

Who this might be right for
Tuberculosis Infection
Oxford University Clinical Research Unit, Vietnam 596
Testing effectiveness (Phase 2)Study completedNCT00755976
What this trial is testing

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Cancer Trials Ireland 32
Not applicableNot Yet RecruitingNCT06842706
What this trial is testing

Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 800
Testing effectiveness (Phase 2)Study completedNCT00028873
What this trial is testing

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 35
Not applicableEnded earlyNCT03944369
What this trial is testing

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms

Who this might be right for
Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects
Kaleido Biosciences 3
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Not applicableUnknownNCT00676754
What this trial is testing

Epidemiology of MDR-TB in Peru

Who this might be right for
TB Multi-drug Resistant
Harvard University Faculty of Medicine 18,544
Early research (Phase 1)Study completedNCT00001570
What this trial is testing

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

Who this might be right for
Kidney NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 46
Large-scale testing (Phase 3)Study completedNCT02142751
What this trial is testing

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Who this might be right for
Infection Due to ESBL Escherichia Coli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 161
Large-scale testing (Phase 3)Ended earlyNCT04729387
What this trial is testing

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 358
Next Page